Xonvea is a prescription medication specifically designed to manage nausea and vomiting during pregnancy, a condition medically known as Nausea and Vomiting of Pregnancy (NVP). It is the first and only medicine licensed in the UK for this purpose. The active ingredients in Xonvea are doxylamine succinate, an antihistamine that helps reduce symptoms of nausea, and pyridoxine hydrochloride, a form of vitamin B6, which has been shown to help alleviate nausea and vomiting. Xonvea is typically prescribed when conservative management of NVP, such as dietary and lifestyle changes, have not been effective. It offers a controlled-release formulation, designed to improve symptoms with a reduced risk of side effects commonly associated with other treatments. This medication is intended for use under the guidance and prescription of a healthcare professional, ensuring its safety and effectiveness for pregnant women experiencing NVP.